← Leaderboards
Indu Parikh
Biomarck Pharmaceuticals, Ltd
$7,398,940
Attributed
$7,398,940
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2005–15$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$7,398,940 · 2
By mechanism
R44$7,298,940 · 1
R43$100,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Asthma”
- James E. Gern · University Of Wisconsin-Madison$159,588,264
- William W. Busse · University Of Wisconsin Madison$104,093,792
- Scott T Weiss · University Of California, San Diego$98,211,117
- David T Mauger · Pennsylvania State Univ Hershey Med Ctr$79,309,576
- Fernando D Martinez · University Of Arizona$66,357,737
- Wanda Phipatanakul · Boston Children'S Hospital$50,505,446
Research focus
AsthmaLeadAccountingMarketingGrantAerosolizedClinical ResearchDouble-Blind MethodEconomic BurdenLung DiseasesCystic FibrosisAirway ObstructionBreathingBronchiectasisFundingCanis FamiliarisDoseCause Of DeathCessation Of LifeChronicMedicalEpithelial CellsBaseMorbidity - Disease Rate
Grant awards (10)
Clinical Development of a Therapeutic Agent for COPD$1,000,000
R44 · FY2015 · HL · contact PI
Clinical Development of a Therapeutic Agent for COPD$1,000,000
R44 · FY2014 · HL · contact PI
Clinical Development of a Therapeutic Agent for COPD$1,000,000
R44 · FY2013 · HL · contact PI
Clinical Development a Therapeutic Agent for COPD$80,000
R44 · FY2010 · HL · contact PI
Clinical Development a Therapeutic Agent for COPD$990,000
R44 · FY2009 · HL · contact PI
Clinical Development a Therapeutic Agent for COPD$1,000,000
R44 · FY2008 · HL · contact PI
Clinical Development a Therapeutic Agent for COPD$1,000,000
R44 · FY2006 · HL · contact PI
Preclinical Development of a Therapeutic Agent for COPD$596,400
R44 · FY2005 · HL
Preclinical Development of a Therapeutic Agent for COPD$632,540
R44 · FY2004 · HL
Inhibition of Mucin Secretion in Murine Model of Asthma$100,000
R43 · FY2003 · HL